Experimental Neurotherapeutics: Surfing the Tidal Wave of New Opportunities

Lauren B Reoma; Ania Busza; M Maral Mouradian; Petra Kaufmann; Erika F Augustine; Samuel Frank; Thomas P Sutula; Andrew J Cole; Heather D Fitter; William Meurer; Avindra Nath; Robert C Griggs

doi:10.1002/ana.26582

Experimental Neurotherapeutics: Surfing the Tidal Wave of New Opportunities

Ann Neurol. 2023 Mar;93(3):427-430. doi: 10.1002/ana.26582. Epub 2023 Jan 16.

Authors

Lauren B Reoma¹, Ania Busza^{2

3}, M Maral Mouradian⁴, Petra Kaufmann^{5

6}, Erika F Augustine⁷, Samuel Frank⁸, Thomas P Sutula⁹, Andrew J Cole¹⁰, Heather D Fitter¹¹, William Meurer^{12

13

14

15

16}, Avindra Nath¹, Robert C Griggs^{2

3}

Affiliations

¹ Clinical Trials Unit, Office of the Clinical Director, National Institute of Neurological Disorders and Stroke, Bethesda, MD, USA.
² University of Rochester School of Medicine and Dentistry, Department of Medicine, Rochester Regional Health; Department of Medicine, Division of Allergy, Immunology, and Rheumatology, Rochester, NY, USA.
³ Department of Neurology, University of Rochester Medical Center, Rochester, NY, USA.
⁴ RWJMS Institute for Neurological Therapeutics and Department of Neurology, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ, USA.
⁵ Affinia Therapeutics, Bannockburn, MA, USA.
⁶ University of Rochester, Rochester, NY, USA.
⁷ Kennedy Krieger Institute, Baltimore, MD, USA.
⁸ Department of Neurology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
⁹ Department of Neurology, University of Wisconsin, Madison, WI, USA.
¹⁰ Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
¹¹ Division of Neurology II, Office of Neuroscience, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD, USA.
¹² Department of Emergency Medicine, University of Michigan, Ann Arbor, MI, USA.
¹³ Michigan Center for Integrative Research in Critical Care, Ann Arbor, MI, USA.
¹⁴ Department of Neurology, University of Michigan, Ann Arbor, MI, USA.
¹⁵ Stroke Program, University of Michigan, Ann Arbor, MI, USA.
¹⁶ Berry Consultants, Austin, TX, USA.

Abstract

The subspecialty of experimental neurotherapeutics trains neurologists in discovering and developing new treatments for neurologic diseases. Based on development of exciting new treatments for genetic and inflammatory diseases, we predict that there will be many other breakthroughs. The job market has expanded rapidly in academia, the pharmaceutical industry, government, and not-for-profit sectors; many new opportunities can be anticipated. The burgeoning opportunities in the field mandate that training address the challenges of overcoming obstacles in therapeutic discovery, implementation science, and development of affordable and equitably available treatments. ANN NEUROL 2023;93:427-430.

Experimental Neurotherapeutics: Surfing the Tidal Wave of New Opportunities

Authors

Affiliations

Abstract

Publication types

MeSH terms

Grants and funding